Literature DB >> 10606223

The infectious complications of anabolic-androgenic steroid injection.

J D Rich1, B P Dickinson, A Feller, D Pugatch, E Mylonakis.   

Abstract

One million individuals in the United States alone are estimated to be current or past users of anabolic-androgenic steroids. In the United States fifty-percent of anabolic-androgenic steroid users administer their compounds intramuscularly, and twenty-five percent of adolescent anabolic-androgenic steroid users share needles, placing these young adults at risk for infections related to injection. To examine the medical literature for reports of infections attributable to anabolic-androgenic steroids, we conducted a MEDLINE (1966-1998) and AIDSLINE (1980-1998) world literature review to examine all references that attributed infections to anabolic-androgenic steroid injection. Infections associated with anabolic-androgenic steroid injection include three cases of HIV, one case of hepatitis B, one case of hepatitis C, eight abscesses, and a case of fungal endophthalmitis. No cross-sectional or prospective studies exist that document the risk of infections related to anabolic-androgenic steroid injection. These serious infectious complications of anabolic-androgenic steroid injection may be avoided with education and prevention techniques. Infections occurring in anabolic-androgenic steroid users are not as common as in intravenous drug users.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606223     DOI: 10.1055/s-1999-8841

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

1.  Doping use among tertiary education students in six developed countries.

Authors:  Fotios C Papadopoulos; Ilias Skalkidis; Jari Parkkari; Eleni Petridou
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

3.  Nonprescription steroids on the Internet.

Authors:  Christen L Clement; Douglas B Marlowe; Nicholas S Patapis; David S Festinger; Robert F Forman
Journal:  Subst Use Misuse       Date:  2011-11-14       Impact factor: 2.164

4.  Drug injection practices among high-risk youths: the first shot of ketamine.

Authors:  Stephen E Lankenau; Michael C Clatts
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

5.  Identification of black market products and potential doping agents in Germany 2010-2013.

Authors:  Oliver Krug; Andreas Thomas; Katja Walpurgis; Thomas Piper; Gerd Sigmund; Wilhelm Schänzer; Tim Laussmann; Mario Thevis
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

Review 6.  Special feature for the Olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes.

Authors:  G Friman; L Wesslén
Journal:  Immunol Cell Biol       Date:  2000-10       Impact factor: 5.126

7.  Body Builder's Nightmare: Black Market Steroid Injection Gone Wrong: a Case Report.

Authors:  Or Friedman; Ehud Arad; Oded Ben Amotz
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-29

Review 8.  Prevention of infectious diseases in athletes.

Authors:  Anthony Luke; Pierre d'Hemecourt
Journal:  Clin Sports Med       Date:  2007-07       Impact factor: 2.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.